NDCs not required under HHS rule
Executive Summary
Neither national drug codes nor the Healthcare Common Procedure Coding System would be required as the standard for reporting drugs and biologics for non-retail pharmacy transactions under HHS proposed rule. NDCs will remain the standard for retail pharmacy. The Pharmaceutical Research & Manufacturers of America wants NDCs to be used as the basis for Medicare reimbursement (1"The Pink Sheet" April 22, p. 36)...
You may also be interested in...
HCPCS Code Six-Month Marketing Prerequisite Is Unnecessary, PhRMA Says
The Centers for Medicare & Medicaid Services should eliminate the six-month marketing prerequisite for applying to receive an HCPCS code for Medicare reimbursement, PhRMA said in comments to HHS' Committee on Regulatory Reform
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.